Telepatía AI, a health technology startup founded in Medellin, Colombia, and incubated at Stanford University, has secured one of the largest digital health investments ever raised by a Latin American company after closing a US$33 million Series A round led by venture capital firm Andreessen Horowitz.
The investment brings the company’s total funding to US$42 million in less than a year and supports its goal of expanding an artificial intelligence platform designed to reduce administrative work for healthcare professionals. Rather than replacing doctors, Telepatía AI acts as a clinical assistant that automatically documents consultations, provides evidence-based recommendations, and integrates with existing hospital systems, allowing physicians and nurses to spend more time with patients instead of completing medical records.
How Telepatía AI assists doctors during medical consultations
Telepatía’s core function centers on listening rather than replacing, since the software captures the spoken conversation between doctor and patient in real time, transcribes it automatically, and generates a structured clinical record that follows each institution’s own documentation format, all without the physician needing to type a single word during the appointment.
Beyond documentation, the platform behaves like a clinical copilot, offering suggestions grounded in scientific evidence and institutional protocols, flagging exams a doctor might have overlooked, and warning against medications that could conflict with a patient’s existing treatment, functioning less like a search engine and more like a specialized assistant that scans medical journals for the answer a physician needs in the middle of a consultation.
The company also built a component it calls the AI Advisor, which works similarly to a general-purpose chatbot but restricts its answers exclusively to peer-reviewed scientific literature, resolving questions about medication dosages, differential diagnoses, or possible clinical management strategies while the appointment is still happening.
Why hospitals can adopt Telepatía AI without replacing existing systems
The feature that separates Telepatia from a simple transcription tool is its integration capacity, since the platform connects directly to more than 50 hospital record systems already in use across the region, including Epic in the United States and Hosvital in Colombia, meaning a doctor never has to copy information from one program and paste it into another.
That integration matters because hospitals rarely have the appetite or budget to replace their entire digital infrastructure just to adopt a new tool, so Telepatía’s approach of working within existing systems rather than demanding a costly migration removes one of the biggest barriers that typically slows down healthtech adoption inside public and private institutions alike.
Doctors using the platform reportedly recover up to two hours per day that they previously spent on documentation, time the company frames as directly convertible into more attention, more patients seen, or simply less professional burnout.
From Medellín to hospitals across Latin America
Since launching less than a year ago, Telepatía has expanded its reach to more than 14 million patients through over 25 public and private health institutions spread across Brazil, Colombia, Mexico, Chile, and Argentina, a growth curve that helped convince Andreessen Horowitz to lead the round after the company had already closed a US$9 million seed round in October 2025.
Inside Colombia specifically, the platform recently began a pilot program at Hospital San Roque in Guacarí, Valle del Cauca, a rural municipality where the tool aims to improve care access for more than 35,000 residents, demonstrating that Telepatía’s ambitions extend beyond large urban hospitals into smaller regional health systems that often face the most acute shortages of medical staff and administrative support.
The personal story driving Telepatía AI’s growth
Part of what drives Abad’s urgency traces back to a personal loss, since reports connect his motivation to found the company to his father’s death, a detail that frames Telepatía less as a purely commercial venture and more as an attempt to prevent the kind of gaps in medical attention and decision-making that technology, used correctly, might have helped avoid.
With its new capital, the company has stated a goal of reaching half of Latin America’s 1.9 million practicing doctors by 2027, a target that would represent one of the most significant technology-driven shifts in how the region’s healthcare professionals spend their working hours, provided hospitals continue adopting the platform at the pace it has shown since its founding.
